When we talk about risk management in clinical trial supply, we’re usually referring to two types of risk:
Read moreInterview by N-SIDE’s Growth Marketing Coordinator, Donokhon Abulkasimova Did you know that N-SIDE has a special team of experts, who power innovation in...
Read moreCOVID vaccines and antivirals sped through clinical trials and regulatory approvals in record time. But these records are even more impressive when you...
Read moreThe development of COVID-19 vaccines in less than a year from when the virus was first sequenced was a monumental achievement. Antiviral medications for COVID...
Read moreClinical trials are becoming more complex. New types of therapy like biologics and personalized medicine, as well as treatments targeting rare diseases, create...
Read moreAre you struggling to smartly aggregate your clinical supply data ? Do you want to transform this data into actionable insights?
Read moreJoin us at the digital edition of the Clinical Trial Supply conference. Due to the COVID-19 situation, the event will be hosted virtually :
Read moreCritical decisions are taken during protocol design. It is essential to maintain patient centricity and respect site constraints, but it is also an opportunity...
Read more